Mitochondria and PGC-1α in aging and age-associated diseases

Journal of Aging Research

Volumn 2011, Issue , 2011, Pages

  Wenz, Tina ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN A; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CELL PROTEIN; ESTROGEN RELATED RECEPTOR ALPHA; GA BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOCHONDRIAL DNA; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTEIN P66; PROTEIN SHC; REACTIVE OXYGEN METABOLITE; RESVERATROL; ROSIGLITAZONE; SIRTUIN 1; SIRTUIN 3; STIMULATORY PROTEIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

AGING; BIOGENESIS; BRAIN FUNCTION; CALCIUM SIGNALING; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL METABOLISM; CELLULAR STRESS RESPONSE; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ELECTRON TRANSPORT; ENDOTHELIAL DYSFUNCTION; EXERCISE; GENE EXPRESSION; GENE MUTATION; HEART FUNCTION; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; LIFESPAN; LIVER METABOLISM; METABOLIC REGULATION; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; NERVE DEGENERATION; NEUROPROTECTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; STEATOSIS;

EID: 84555200221     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.4061/2011/810619     Document Type: Review

References (144)

1. Harman D., The biologic clock: the mitochondria? Journal of the American Geriatrics Society 1972 20 4 145 147 2-s2.0-0015319592
2. Trifunovic A., Larsson N. G., Mitochondrial dysfunction as a cause of ageing. Journal of Internal Medicine 2008 263 2 167 178 2-s2.0-38349108752 10.1111/j.1365-2796.2007.01905.x
3. Lanza I. R., Nair K. S., Mitochondrial function as a determinant of life span. Pflugers Archiv European Journal of Physiology 2010 459 2 277 289 2-s2.0-73749087580 10.1007/s00424-009-0724-5
4. Guarente L., Mitochondria-A nexus for aging, calorie restriction, and sirtuins? Cell 2008 132 2 171 176 2-s2.0-38649132337 10.1016/j.cell.2008.01.007 (Pubitemid 351172441)
5. Handschin C., The biology of PGC-1 α and its therapeutic potential. Trends in Pharmacological Sciences 2009 30 6 322 329 2-s2.0-68649109608 10.1016/j.tips.2009.03.006
6. Wenz T., PGC-1 α activation as a therapeutic approach in mitochondrial disease. IUBMB Life 2009 61 11 1051 1062 2-s2.0-77449139468 10.1002/iub.261
7. Saraste M., Oxidative phosphorylation at the fin de siecle. Science 1999 283 5407 1488 1493 2-s2.0-0033525924 10.1126/science.283.5407.1488 (Pubitemid 29133351)
8. Orrenius S., Gogvadze V., Zhivotovsky B., Mitochondrial oxidative stress: implications for cell death. Annual Review of Pharmacology and Toxicology 2007 47 143 183 2-s2.0-33847045900 10.1146/annurev.pharmtox.47.120505.105122
9. Andreyev A. Y., Kushnareva YU. E., Starkov A. A., Mitochondrial metabolism of reactive oxygen species. Biochemistry 2005 70 2 200 214 2-s2.0-17144422877 10.1007/s10541-005-0102-7 (Pubitemid 40512329)
10. Cadenas E., Davies K. J. A., Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biology and Medicine 2000 29 3-4 222 230 2-s2.0-0033796250 10.1016/S0891-5849(00)00317-8
11. St-Pierre J., Buckingham J. A., Roebuck S. J., Brand M. D., Topology of superoxide production from different sites in the mitochondrial electron transport chain. The Journal of Biological Chemistry 2002 277 47 44784 44790 2-s2.0-0037160091 10.1074/jbc.M207217200 (Pubitemid 36159072)
12. Miquel J., Economos A. C., Fleming J., Johnson J. E., Mitochondrial role in cell aging. Experimental Gerontology 1980 15 6 575 591 2-s2.0-0019160038 10.1016/0531-5565(80)90010-8 (Pubitemid 11243249)
13. Kujoth C. C., Hiona A., Pugh T. D., Someya S., Panzer K., Wohlgemuth S. E., Hofer T., Seo A. Y., Sullivan R., Jobling W. A., Morrow J. D., Van Remmen H., Sedivy J. M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T. A., Medicine: mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005 309 5733 481 484 2-s2.0-22344456832 10.1126/science.1112125 (Pubitemid 40994689)
14. Trifunovic A., Hansson A., Wredenberg A., Rovio A. T., Dufour E., Khvorostov I., Spelbrink J. N., Wibom R., Jacobs H. T., Larsson N. G., Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proceedings of the National Academy of Sciences of the United States of America 2005 102 50 17993 17998 2-s2.0-29144458899 10.1073/pnas.0508886102 (Pubitemid 41798490)
15. Wang J., Silva J. P., Gustafsson C. M., Rustin P., Larsson N. G., Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4038 4043 2-s2.0-0035957398 10.1073/pnas.061038798 (Pubitemid 32249894)
16. Balaban R. S., Nemoto S., Finkel T., Mitochondria, oxidants, and aging. Cell 2005 120 4 483 495 2-s2.0-13944278132 10.1016/j.cell.2005.02.001 (Pubitemid 40269763)
17. Van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S. R., Alderson N. L., Baynes J. W., Epstein C. J., Huang T. T., Nelson J., Strong R., Richardson A., Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiological Genomics 2004 16 29 37 2-s2.0-12144288373 10.1152/physiolgenomics. 00122.2003 (Pubitemid 38420018)
18. Van Remmen H., Qi W., Sabia M., Freeman G., Estlack L., Yang H., Guo Z. M., Huang T. T., Strong R., Lee S., Epstein C. J., Richardson A., Multiple deficiencies in antioxidant enzymes in mice result in a compound increase in sensitivity to oxidative stress. Free Radical Biology and Medicine 2004 36 12 1625 1634 2-s2.0-2942556985 10.1016/j.freeradbiomed.2004.03.016 (Pubitemid 38746568)
19. Huang T. T., Carlson E. J., Gillespie A. M., Shi Y., Epstein C. J., Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. Journals of Gerontology-Series A 2000 55 1 B5 B9 2-s2.0-0034006162 (Pubitemid 30140724)
20. Miwa S., Riyahi K., Partridge L., Brand M. D., Lack of correlation between mitochondrial reactive oxygen species production and life span in Drosophila. Annals of the New York Academy of Sciences 2004 1019 388 391 2-s2.0-3242737464 10.1196/annals.1297.069 (Pubitemid 38951342)
21. Lee H.-Y., Choi C. S., Birkenfeld A. L., Alves T. C., Jornayvaz F. R., Jurczak M. J., Zhang D., Woo D. K., Shadel G. S., Ladiges W., Rabinovitch P. S., Santos J. H., Petersen K. F., Samuel V. T., Shulman G. I., gerald.shulman@yale. edu Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metabolism 2010 12 6 668 674 10.1016/j.cmet.2010.11.004
22. Dai D. F., Santana L. F., Vermulst M., Tomazela D. M., Emond M. J., MacCoss M. J., Gollahon K., Martin G. M., Loeb L. A., Ladiges W. C., Rabinovitch P. S., Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009 119 21 2789 2797 2-s2.0-67649204729 10.1161/CIRCULATIONAHA.108.822403
23. Treuting P. M., Linford N. J., Knoblaugh S. E., Emond M. J., Morton J. F., Martin G. M., Rabinovitch P. S., Ladiges W. C., Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. Journals of Gerontology-Series A 2008 63 8 813 824 2-s2.0-53349153165
24. Schriner S. E., Linford N. J., Martin G. M., Treuting P., Ogburn C. E., Emond M., Coskun P. E., Ladiges W., Wolf N., Van Remmen H., Wallace D. C., Rabinovitch P. S., Medecine: extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005 308 5730 1909 1911 2-s2.0-21144434217 10.1126/science.1106653 (Pubitemid 40941874)
25. Ergen A. V., Goodell M. A., Mechanisms of hematopoietic stem cell aging. Experimental Gerontology 2010 45 4 286 290 2-s2.0-77649337753 10.1016/j.exger.2009.12.010
26. Someya S., Prolla T. A., taprolla@wisc.edu Mitochondrial oxidative damage and apoptosis in age-related hearing loss. Mechanisms of Ageing and Development 2010 131 7-8 480 486 10.1016/j.mad.2010.04.006
27. Ohlemiller K. K., McFadden S. L., Ding DA. L., Flood D. G., Reaume A. G., Hoffman E. K., Scott R. W., Wright J. S., Putcha G. V., Salvi R. J., Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss. Audiology and Neuro-Otology 1999 4 5 237 246 2-s2.0-0032767363 10.1159/000013847 (Pubitemid 29366436)
28. Someya S., Xu J., Kondo K., Ding D., Salvi R. J., Yamasoba T., Rabinovitch P. S., Weindruch R., Leeuwenburgh C., Tanokura M., Prolla T. A., Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 46 19432 19437 2-s2.0-73349109524 10.1073/pnas.0908786106
29. Li F., Calingasan N. Y., Yu F., Mauck W. M., Toidze M., Almeida C. G., Takahashi R. H., Carlson G. A., Beal M. F., Lin M. T., Gouras G. K., Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. Journal of Neurochemistry 2004 89 5 1308 1312 2-s2.0-2642544767 10.1111/j.1471-4159. 2004.02455.x (Pubitemid 38715849)
30. Melov S., Adlard P. A., Morten K., Johnson F., Golden T. R., Hinerfeld D., Schilling B., Mavros C., Masters C. L., Volitakis I., Li Q. X., Laughton K., Hubbard A., Cherny R. A., Gibson B., Bush A. I., Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2007 2 6, article e536 2-s2.0-38849150935 10.1371/journal.pone.0000536 (Pubitemid 351194010)
31. Ohashi M., Runge M. S., Faraci F. M., Heistad D. D., MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 10 2331 2336 2-s2.0-33749072055 10.1161/01.ATV.0000238347.77590.c9 (Pubitemid 44465730)
32. Vincent A. M., Russell J. W., Sullivan K. A., Backus C., Hayes J. M., McLean L. L., Feldman E. L., SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Experimental Neurology 2007 208 2 216 227 2-s2.0-36048968888 10.1016/j.expneurol.2007.07.017 (Pubitemid 350101499)
33. Albers D. S., Flint Beal M., Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. Journal of Neural Transmission, Supplement 2000 59 133 154 2-s2.0-0033624419 (Pubitemid 30479414)
34. Ristow M., Zarse K., How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Experimental Gerontology 2010 45 6 410 418 2-s2.0-77952548782 10.1016/j.exger.2010.03.014
35. Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., Stumvoll M., Kahn C. R., Blüher M., Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences of the United States of America 2009 106 21 8665 8670 2-s2.0-66649109663 10.1073/pnas.0903485106
36. Bjelakovic G., Nikolova D., Gluud L. L., Simonetti R. G., Gluud C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Journal of the American Medical Association 2007 297 8 842 857 2-s2.0-33847378451 10.1001/jama.297.8.842 (Pubitemid 46333949)
37. Yang W., Hekimi S., Siegfried.Hekimi@McGill.ca A mitochondrial superoxide signal triggers increased longevity in caenorhabditis elegans. PLoS Biology 2010 8 12 e1000556 10.1371/journal.pbio.1000556
38. Scherz-Shouval R., Elazar Z., zvulun.elazar@weizmann.ac.il Regulation of autophagy by ROS: physiology and pathology. Trends in Biochemical Sciences 2011 36 1 30 38 10.1016/j.tibs.2010.07.007
39. Papaconstantinou J., Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Molecular and Cellular Endocrinology 2009 299 1 89 100 2-s2.0-58349097705 10.1016/j.mce.2008.11.025
40. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., Pelicci P. G., Electron transfer between cytochrome c and p66 generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005 122 2 221 233 2-s2.0-22744447211 10.1016/j.cell.2005.05.011 (Pubitemid 41032986)
41. Scarpulla R. C., Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiological Reviews 2008 88 2 611 638 2-s2.0-42049114034 10.1152/physrev.00025.2007 (Pubitemid 351520089)
42. Scarpulla R. C., Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Annals of the New York Academy of Sciences 2008 1147 321 334 2-s2.0-57649148823 10.1196/annals.1427.006
43. Puigserver P., Spiegelman B. M., Peroxisome proliferator-activated receptor- γ coactivator 1 α (PGC-1 α): transcriptional coactivator and metabolic regulator. Endocrine Reviews 2003 24 1 78 90 2-s2.0-0037326196 10.1210/er.2002-0012 (Pubitemid 36223280)
44. Kang D., Hamasaki N., Mitochondrial transcription factor A in the maintenance of mitochondrial DNA: overview of its multiple roles. Annals of the New York Academy of Sciences 2005 1042 101 108 2-s2.0-22044443172 10.1196/annals.1338.010 (Pubitemid 40967627)
45. Bastin J., Aubey F., Rötig A., Munnich A., Djouadi F., Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. Journal of Clinical Endocrinology and Metabolism 2008 93 4 1433 1441 2-s2.0-42049114658 10.1210/jc.2007-1701 (Pubitemid 351519745)
46. Wenz T., Diaz F., Spiegelman B. M., Moraes C. T., Activation of the PPAR/PGC-1 α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metabolism 2008 8 3 249 256 2-s2.0-50049118173 10.1016/j.cmet.2008.07.006
47. Wenz T., A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations. Journal of Cellular and Molecular Medicine. In press
48. Barrès R., Osler M. E., Yan J., Rune A., Fritz T., Caidahl K., Krook A., Zierath J. R., Non-CpG Methylation of the PGC-1 α Promoter through DNMT3B Controls Mitochondrial Density. Cell Metabolism 2009 10 3 189 198 2-s2.0-69149087790 10.1016/j.cmet.2009.07.011
49. Fan M., Rhee J., St-Pierre J., Handschin C., Puigserver P., Lin J., Jäeger S., Erdjument-Bromage H., Tempst P., Spiegelman B. M., Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1 α: modulation by p38 MAPK. Genes and Development 2004 18 3 278 289 2-s2.0-10744222588 10.1101/gad.1152204 (Pubitemid 38199253)
50. Powelka A. M., Seth A., Virbasius J. V., Kiskinis E., Nicoloro S. M., Guilherme A., Tang X., Straubhaar J., Cherniack A. D., Parker M. G., Czech M. P., Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. Journal of Clinical Investigation 2006 116 1 125 136 2-s2.0-31044432605 10.1172/JCI26040 (Pubitemid 43121797)
51. Cantó C., Auwerx J., PGC-1 α SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology 2009 20 2 98 105 2-s2.0-64549127790 10.1097/MOL.0b013e328328d0a4
52. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1 α Cell 2006 127 6 1109 1122 2-s2.0-33845399894 10.1016/j.cell.2006.11.013 (Pubitemid 44894520)
53. Planavila A., Sirt1 acts in association with PPAR α to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovascular Research. In press
54. Beher D., Wu J., Cumine S., Kim KI. W., Lu S. C., Atangan L., Wang M., Resveratrol is not a direct activator of sirt1 enzyme activity. Chemical Biology and Drug Design 2009 74 6 619 624 2-s2.0-70350524083 10.1111/j.1747-0285.2009. 00901.x
55. Dai H., Kustigian L., Carney D., Case A., Considine T., Hubbard B. P., Perni R. B., Riera T. V., Szczepankiewicz B., Vlasuk G. P., Stein R. L., rstein@sirtrispharma.com SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. The Journal of Biological Chemistry 2010 285 43 32695 32703 10.1074/jbc.M110.133892
56. Ling C., Poulsen P., Carlsson E., Ridderstråle M., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., Vaag A., Multiple environmental and genetic factors influence skeletal muscle PGC-1 α and PGC-1 β gene expression in twins. Journal of Clinical Investigation 2004 114 10 1518 1526 2-s2.0-15244352847 10.1172/JCI200421889 (Pubitemid 40385582)
57. Southgate R. J., Bruce C. R., Carey A. L., Steinberg G. R., Walder K., Monks R., Watt M. J., Hawley J. A., Birnbaum M. J., Febbraio M. A., PGC-1 α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. FASEB Journal 2005 19 14 2072 2074 2-s2.0-28744459153 10.1096/fj.05-3993fje (Pubitemid 41759769)
58. Akimoto T., Pohnert S. C., Li P., Zhang M., Gumbs C., Rosenberg P. B., Williams R. S., Yan Z., Exercise stimulates Pgc-1 α transcription in skeletal muscle through activation of the p38 MAPK pathway. The Journal of Biological Chemistry 2005 280 20 19587 19593 2-s2.0-21244477127 10.1074/jbc.M408862200 (Pubitemid 41379480)
59. Anderson R. M., Barger J. L., Edwards M. G., Braun K. H., O'connor C. E., Prolla T. A., Weindruch R., Dynamic regulation of PGC-1 α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell 2008 7 1 101 111 2-s2.0-38349130508 10.1111/j.1474-9726.2007.00357.x
60. Housley M. P., Udeshi N. D., Rodgers J. T., Shabanowitz J., Puigserver P., Hunt D. F., Hart G. W., A PGC-1 α -O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. The Journal of Biological Chemistry 2009 284 8 5148 5157 2-s2.0-64149111641 10.1074/jbc.M808890200
61. Rytinki M. M., Palvimo J. J., SUMOylation attenuates the function of PGC-1 α The Journal of Biological Chemistry 2009 284 38 26184 26193 2-s2.0-70350031566 10.1074/jbc.M109.038943
62. DiMauro S., Schon E. A., Mitochondrial disorders in the nervous system. Annual Review of Neuroscience 2008 31 91 123 2-s2.0-48249156188 10.1146/annurev.neuro.30.051606.094302
63. Baker D. J., Betik A. C., Krause D. J., Hepple R. T., No decline in skeletal muscle oxidative capacity with aging in long-term calorically restricted rats: effects are independent of mitochondrial DNA integrity. Journals of Gerontology-Series A 2006 61 7 675 684 2-s2.0-33746655748 (Pubitemid 44148352)
64. Civitarese A. E., Carling S., Heilbronn L. K., Hulver M. H., Ukropcova B., Deutsch W. A., Smith S. R., Ravussin E., Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Medicine 2007 4 3 485 494 2-s2.0-33947710793 10.1371/journal.pmed.0040076 (Pubitemid 46495316)
65. Fadini G. P., gianpaolofadini@hotmail.com Ceolotto G., Pagnin E., De Kreutzenberg S., Avogaro A., At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell 2011 10 1 10 17 10.1111/j.1474-9726.2010.00642.x
66. Sahin E., Colla S., Liesa M., Moslehi J., Müller F. L., Guo M., Cooper M., Kotton D., Fabian A. J., Walkey C., Maser R. S., Tonon G., Foerster F., Xiong R., Wang Y. A., Shukla S. A., Jaskelioff M., Martin E. S., Heffernan T. P., Protopopov A., Ivanova E., Mahoney J. E., Kost-Alimova M., Perry S. R., Bronson R., Liao R., Mulligan R., Shirihai O. S., Chin L., DePinho R. A., rondepinho@dfci.harvard.edu Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011 470 7334 359 365 10.1038/nature09787
67. Gonzalez A. A., Kumar R., Mulligan J. D., Davis A. J., Saupe K. W., kws@medicine.wisc.edu Effects of aging on cardiac and skeletal muscle AMPK activity: basal activity, allosteric activation, and response to in vivo hypoxemia in mice. American Journal of Physiology 2004 287 5 56-5 R1270 R1275 10.1152/ajpregu.00409.2004 (Pubitemid 39391076)
68. Wenz T., Rossi S. G., Rotundo R. L., Spiegelman B. M., Moraes C. T., Increased muscle PGC-1 α expression protects from sarcopenia and metabolic disease during aging. Proceedings of the National Academy of Sciences of the United States of America 2010 106 48 20405 20410 2-s2.0-73949099327 10.1073/pnas.0911570106
69. Baar K., Wende A. R., Jones T. E., Marison M., Nolte L. A., Chen M., Kelly D. P., Holloszy J. O., Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB Journal 2002 16 14 1879 1886 2-s2.0-0036903174 10.1096/fj.02-0367com (Pubitemid 35462607)
70. Handschin C., christoph.handschin@unibas.ch Regulation of skeletal muscle cell plasticity by the peroxisome proliferator-activated receptor γ coactivator 1 α Journal of Receptors and Signal Transduction 2010 30 6 376 384 10.3109/10799891003641074
71. Cao W., Daniel K. W., Robidoux J., Puigserver P., Medvedev A. V., Bai XU., Floering L. M., Spiegelman B. M., Collins S., p38 Mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Molecular and Cellular Biology 2004 24 7 3057 3067 2-s2.0-1642293248 10.1128/MCB.24.7.3057-3067.2004 (Pubitemid 38381292)
72. Puigserver P., Rhee J., Lin J., Wu Z., Yoon J. C., Zhang C. Y., Krauss S., Mootha V. K., Lowell B. B., Spiegelman B. M., Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR γ coactivator-1. Molecular Cell 2001 8 5 971 982 2-s2.0-18244399631 10.1016/S1097-2765(01)00390-2 (Pubitemid 34031800)
73. Lin J., Wu H., Tarr P. T., Zhang C. Y., Wu Z., Boss O., Michael L. F., Puigserver P., Isotani E., Olson E. N., Lowell B. B., Bassel-Duby R., Spiegelman B. M., Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibres. Nature 2002 418 6899 797 801 2-s2.0-0037102256 10.1038/nature00904
74. Wenz T., Diaz F., Hernandez D., Moraes C. T., Endurance exercise is protective for mice with mitochondrial myopathy. Journal of Applied Physiology 2009 106 5 1712 1719 2-s2.0-66349120223 10.1152/japplphysiol.91571.2008
75. Handschin C., Kobayashi Y. M., Chin S., Seale P., Campbell K. P., Spiegelman B. M., PGC-1 α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes and Development 2007 21 7 770 783 2-s2.0-34147109662 10.1101/gad.1525107 (Pubitemid 46572357)
76. Sandri M., Lin J., Handschin C., Yang W., Arany Z. P., Lecker S. H., Goldberg A. L., Spiegelman B. M., PGC-1 α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences of the United States of America 2006 103 44 16260 16265 2-s2.0-33750825245 10.1073/pnas.0607795103 (Pubitemid 44715184)
77. Arnold A. -S., Egger A., Handschin C., christoph.handschin@unibas.ch PGC-1 α and myokines in the aging muscle-a mini-review. Gerontology 2010 57 1 37 43 10.1159/000281883
78. Handschin C., Peroxisome proliferator-activated receptor- γ coactivator-1 α in muscle links metabolism to inflammation. Clinical and Experimental Pharmacology and Physiology 2009 36 12 1139 1143 2-s2.0-72149099919 10.1111/j.1440-1681.2009.05275.x
79. Chinsomboon J., Ruas J., Gupta R. K., Thom R., Shoag J., Rowe G. C., Sawada N., Raghuram S., Arany Z., The transcriptional coactivator PGC-1 α mediates exercise-induced angiogenesis in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America 2009 106 50 21401 21406 2-s2.0-75849155745 10.1073/pnas.0909131106
80. Lee C. M., Lopez M. E., Weindruch R., Aiken J. M., Association of age-related mitochondrial abnormalities with skeletal muscle fiber atrophy. Free Radical Biology and Medicine 1998 25 8 964 972 2-s2.0-0032533691 10.1016/S0891-5849(98)00185-3 (Pubitemid 28538563)
81. Marzetti E., Lees H. A., Wohlgemuth S. E., Leeuwenburgh C., Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. BioFactors 2009 35 1 28 35 2-s2.0-65549136627 10.1002/biof.5
82. Huss J. M., Kelly D. P., Nuclear receptor signaling and cardiac energetics. Circulation Research 2004 95 6 568 578 2-s2.0-4644231528 10.1161/01.RES.0000141774.29937.e3 (Pubitemid 39274371)
83. Czubryt M. P., Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 α (PGC-1 α) and mitochondrial function by MEF2 and HDAC5. Proceedings of the National Academy of Sciences of the United States of America 2003 100 4 1711 1716 (Pubitemid 36254513)
84. O'Neill B. T., Kim J., Wende A. R., Theobald H. A., Tuinei J., Buchanan J., Guo A., Zaha V. G., Davis D. K., Schell J. C., Boudina S., Wayment B., Litwin S. E., Shioi T., Izumo S., Birnbaum M. J., Abel E. D., A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metabolism 2007 6 4 294 306 2-s2.0-34548850040 10.1016/j.cmet.2007.09.001 (Pubitemid 47450187)
85. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., Ahmad F., Matsui T., Chin S., Wu P. H., Rybkin I. I., Shelton J. M., Manieri M., Cinti S., Schoen F. J., Bassel-Duby R., Rosenzweig A., Ingwall J. S., Spiegelman B. M., Transcriptional coactivator PGC-1 α controls the energy state and contractile function of cardiac muscle. Cell Metabolism 2005 1 4 259 271 2-s2.0-22144434964 10.1016/j.cmet.2005.03.002 (Pubitemid 43960608)
86. Leone T. C., Lehman J. J., Finck B. N., Schaeffer P. J., Wende A. R., Boudina S., Courtois M., Wozniak D. F., Sambandam N., Bernal-Mizrachi C., Chen Z., Holloszy J. O., Medeiros D. M., Schmidt R. E., Saffitz J. E., Abel E. D., Semenkovich C. F., Kelly D. P., PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biology 2005 3 4 e101 2-s2.0-33644873634
87. Huss J. M., Kelly D. P., Mitochondrial energy metabolism in heart failure: a question of balance. Journal of Clinical Investigation 2005 115 3 547 555 2-s2.0-14644425217 10.1172/JCI200524405 (Pubitemid 40322224)
88. Russell L. K., Mansfield C. M., Lehman J. J., Kovacs A., Courtois M., Saffitz J. E., Medeiros D. M., Valencik M. L., McDonald J. A., Kelly D. P., Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1 α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circulation Research 2004 94 4 525 533 2-s2.0-12144286554 10.1161/01.RES.0000117088.36577.EB (Pubitemid 38326288)
89. Lynn E. G., Stevens M. V., Wong R. P., Carabenciov D., Jacobson J., Murphy E., Sack M. N., sackm@nhlbi.nih.gov Transient upregulation of PGC-1 α diminishes cardiac ischemia tolerance via upregulation of ANT1. Journal of Molecular and Cellular Cardiology 2010 49 4 693 698 10.1016/j.yjmcc.2010.06. 008
90. Rowe G. C., Jiang A., Arany Z., zarany@bidmc.harvard.edu PGC-1 coactivators in cardiac development and disease. Circulation Research 2010 107 7 825 838 10.1161/CIRCRESAHA.110.223818
91. St-Pierre J., Drori S., Uldry M., Silvaggi J. M., Rhee J., Jäger S., Handschin C., Zheng K., Lin J., Yang W., Simon D. K., Bachoo R., Spiegelman B. M., Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006 127 2 397 408 2-s2.0-33749999530 10.1016/j.cell.2006.09.024 (Pubitemid 44572377)
92. Lin J., Wu P. H., Tarr P. T., Lindenberg K. S., St-Pierre J., Zhang C. Y., Mootha V. K., Jäger S., Vianna C. R., Reznick R. M., Cui L., Manieri M., Donovan MI. X., Wu Z., Cooper M. P., Fan M. C., Rohas L. M., Zavacki A. M., Cinti S., Shulman G. I., Lowell B. B., Krainc D., Spiegelman B. M., Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1 α null mice. Cell 2004 119 1 121 135 2-s2.0-5344252327 10.1016/j.cell.2004.09.013 (Pubitemid 39349325)
93. Cowell R. M., Talati P., Blake K. R., Meador-Woodruff J. H., Russell J. W., Identification of novel targets for PGC-1 α and histone deacetylase inhibitors in neuroblastoma cells. Biochemical and Biophysical Research Communications 2009 379 2 578 582 2-s2.0-58149498184 10.1016/j.bbrc.2008.12.109
94. Bender A., Krishnan K. J., Morris C. M., Taylor G. A., Reeve A. K., Perry R. H., Jaros E., Hersheson J. S., Betts J., Klopstock T., Taylor R. W., Turnbull D. M., High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genetics 2006 38 5 515 517 2-s2.0-33646375711 10.1038/ng1769
95. Cui L., Jeong H., Borovecki F., Parkhurst C. N., Tanese N., Krainc D., Transcriptional Repression of PGC-1 α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration. Cell 2006 127 1 59 69 2-s2.0-33749042331 10.1016/j.cell.2006.09.015 (Pubitemid 44466642)
96. Weydt P., Pineda V. V., Torrence A. E., Libby R. T., Satterfield T. F., Lazarowski E., Gilbert M. L., Morton G. J., Bammler T. K., Strand A. D., Cui L., Beyer R. P., Easley C. N., Smith A. C., Krainc D., Luquet S., Sweet I., Schwartz M. W., La Spada A. R., Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1 α in Huntington's disease neurodegeneration. Cell Metabolism 2006 4 5 349 362 2-s2.0-33750437278 10.1016/j.cmet.2006.10.004 (Pubitemid 44645069)
97. Qin W., Haroutunian V., Katsel P., Cardozo C. P., Ho L., Buxbaum J. D., Pasinetti G. M., PGC-1 α expression decreases in the Alzheimer disease brain as a function of dementia. Archives of Neurology 2009 66 3 352 361 2-s2.0-62449166389 10.1001/archneurol.2008.588
98. Sun A. Y., Wang Q., Simonyi A., Sun G. Y., Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases. Molecular Neurobiology 2010 1 9 2-s2.0-77949462435 10.1007/s12035-010-8111-y
99. Yoon J. C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C. R., Granner D. K., Newgard C. B., Spiegelman B. M., Control of hepatic gluconeogenesis through the transcriptional coaotivator PGC-1. Nature 2001 413 6852 131 138 2-s2.0-0035855858 10.1038/35093050 (Pubitemid 32867868)
100. Puigserver P., Rhee J., Donovan J., Walkey C. J., Yoon J. C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B. M., Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1 α interaction. Nature 2003 423 6939 550 555 2-s2.0-0038187621 10.1038/nature01667 (Pubitemid 36648580)
101. Rhee J., Inoue Y., Yoon J. C., Puigserver P., Fan M., Gonzalez F. J., Spiegelman B. M., brucespiegelman@dfci.harvard.edu Regulation of hepatic fasting response by PPAR γ coactivator-1 α (PGC-1): requirement for hepatocyte nuclear factor 4 α in gluconeogenesis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 4012 4017 10.1073/pnas.0730870100 (Pubitemid 36418148)
102. Cao W., Collins Q. F., Becker T. C., Robidoux J., Lupo E. G., Xiong Y., Daniel K. W., Floering L., Collins S., p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. The Journal of Biological Chemistry 2005 280 52 42731 42737 2-s2.0-30044436829 10.1074/jbc.M506223200 (Pubitemid 43049233)
103. Qu F. C., Xiong Y., Lupo E. G., Liu H. Y., Cao W., p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. The Journal of Biological Chemistry 2006 281 34 24336 24344 2-s2.0-33748299056 10.1074/jbc.M602177200 (Pubitemid 44321471)
104. Hancock C. R., Han D. H., Chen M., Terada S., Yasuda T., Wright D. C., Holloszy J. O., High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proceedings of the National Academy of Sciences of the United States of America 2008 105 22 7815 7820 2-s2.0-45549089279 10.1073/pnas.0802057105 (Pubitemid 351872721)
105. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsoe R., Dela F., Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007 50 4 790 796 2-s2.0-33847611885 10.1007/s00125-007- 0594-3 (Pubitemid 46355830)
106. Pospisilik J. A., Knauf C., Joza N., Benit P., Orthofer M., Cani P. D., Ebersberger I., Nakashima T., Sarao R., Neely G., Esterbauer H., Kozlov A., Kahn C. R., Kroemer G., Rustin P., Burcelin R., Penninger J. M., Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007 131 3 476 491 2-s2.0-35548999739 10.1016/j.cell.2007.08.047 (Pubitemid 350017761)
107. Petersen K. F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D. L., DiPietro L., Cline G. W., Shulman G. I., Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003 300 5622 1140 1142 2-s2.0-0038025371 10.1126/science.1082889 (Pubitemid 36583097)
108. Dumas J. F., Simard G., Flamment M., Ducluzeau P. H., Ritz P., Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans? Diabetes and Metabolism 2009 35 3 159 167 2-s2.0-67349265189 10.1016/j.diabet.2009.02.002
109. Kim J. A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance. Circulation Research 2008 102 4 401 414 2-s2.0-41949114990 10.1161/CIRCRESAHA.107.165472 (Pubitemid 351651099)
110. Patti M. E., Butte A. J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E. J., Goldfine A. B., Mun E., DeFronzo R., Finlayson J., Kahn C. R., Mandarino L. J., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471 2-s2.0-0037477855 10.1073/pnas.1032913100 (Pubitemid 36842568)
111. Wang S., Kamat A., Pergola P., Swamy A., Tio F., Cusi K., cusi@uthscsa.edu Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo. Metabolism. In press
112. Gupte A. A., Liu J. Z., Ren Y., Minze L. J., Wiles J. R., Collins A. R.,
113. Hayashi Y., Yoshida M., Yamato M., Ide T., Wu Z., Ochi-Shindou M., Kanki T., Kang D., Sunagawa K., Tsutsui H., Nakanishi H., Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor A in mice. Journal of Neuroscience 2008 28 34 8624 8634 2-s2.0-51649126499 10.1523/JNEUROSCI.1957-08.2008
114. Xu S., Zhong M., Zhang L., Wang Y., Zhou Z., Hao Y., Zhang W., Yang X., Wei A., Pei L., Yu Z., yuzping@yahoo.com Overexpression of Tfam protects mitochondria against β -amyloid-induced oxidative damage in SH-SY5Y cells. FEBS Journal 2009 276 14 4224 4233 10.1111/j.1742-4658.2009.07094.x
115. Ikeuchi M., Matsusaka H., Kang D., Matsushima S., Ide T., Kubota T., Fujiwara T., Hamasaki N., Takeshita A., Sunagawa K., Tsutsui H., htsutsui@med.hokudai.ac.jp Overexpression of mitochondrial transcription factor A ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation 2005 112 5 683 690 10.1161/CIRCULATIONAHA.104.524835 (Pubitemid 41099047)
116. Mahishi L., Usdin K., NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2). Biochemical Journal 2006 400 2 327 335 2-s2.0-33845227580 10.1042/BJ20060734 (Pubitemid 44852045)
117. Rosmarin A. G., Resendes K. K., Yang Z., McMillan J. N., Fleming S. L., GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions. Blood Cells, Molecules, and Diseases 2004 32 1 143 154 2-s2.0-0742306875 10.1016/j.bcmd.2003. 09.005 (Pubitemid 38147712)
118. Yu S., Cui K., Jothi R., Zhao D. -M., Jing X., Zhao K., Xue H. -H., hai-hui-xue@uiowa.edu GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. Blood 2011 117 7 2166 2178 10.1182/blood-2010-09-306563
119. Angus L. M., Chakkalakal J. V., Méjat A., Eibl J. K., Bélanger G., Megeney L. A., Chin E. R., Schaeffer L., Michel R. N., Jasmin B. J., Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1 α drives utrophin gene expression at the neuromuscular junction. American Journal of Physiology 2005 289 4 C908 C917 2-s2.0-25444500449 10.1152/ajpcell.00196.2005 (Pubitemid 41361647)
120. Kong X., Wang R., Xue Y., Liu X., Zhang H., Chen Y., cy101610@npc.gov.cn Fang F., fangfd@vip.sina.com Chang Y., changy@ibms.pumc.edu.cn Sirtuin 3, a new target of PGC-1 α plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 2010 5 7 e11707 10.1371/journal.pone.0011707
121. Verdin E., everdin@gladstone.ucsf.edu Hirschey M. D., Finley L. W.S., Haigis M. C., marciahaigis@hms.harvard.edu Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends in Biochemical Sciences 2010 35 12 669 675 10.1016/j.tibs.2010.07.003
122. Hafner A. V., Dai J., Gomes A. P., Xiao C. Y., Palmeira C. M., Rosenzweig A., Sinclair D. A., Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2010 2 12 914 923
123. Sadoshima J., Sirt3 targets mPTP and prevents aging in the heart. Aging 2011 3 1 12 13
124. Bartke A., Masternak M., Al-Regaiey K., Bonkowski M., Effects of dietary restriction on the expression of insulin-signaling- related genes in long-lived mutant mice. Interdisciplinary Topics in Gerontology 2007 35 69 82 2-s2.0-33846539489 10.1159/000096556
125. Bordone L., Guarente L., Calorie restriction, SIRT1 and metabolism: understanding longevity. Nature Reviews Molecular Cell Biology 2005 6 4 298 305 2-s2.0-17144429302 10.1038/nrm1616 (Pubitemid 40516896)
126. Lin S. J., Guarente L., Increased life span due to calorie restriction in respiratory-deficient yeast. PLoS Genetics 2006 2 3 e33
127. Ramsey J. J., Colman R. J., Binkley N. C., Christensen J. D., Gresl T. A., Kemnitz J. W., Weindruch R., Dietary restriction and aging in rhesus monkeys: the University of Wisconsin study. Experimental Gerontology 2000 35 9-10 1131 1149 2-s2.0-0033653974 10.1016/S0531-5565(00)00166-2
128. Weindruch R., Walford R. L., Fligiel S., Guthrie D., The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. Journal of Nutrition 1986 116 4 641 654 2-s2.0-0022517746 (Pubitemid 16066430)
129. Civitarese A. E., Smith S. R., Ravussin E., Diet, energy metabolism and mitochondrial biogenesis. Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 6 679 687 2-s2.0-37349073763 10.1097/MCO.0b013e3282f0ecd2 (Pubitemid 350293767)
130. Rodgers J. T., Lerin C., Gerhart-Hines Z., Puigserver P., perepuigserver@dfci.harvard.edu Metabolic adaptations through the PGC-1 α and SIRT1 pathways. FEBS Letters 2008 582 1 46 53 10.1016/j.febslet.2007.11.034 (Pubitemid 350297246)
131. Nemoto S., Fergusson M. M., Finkel T., SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1 α The Journal of Biological Chemistry 2005 280 16 16456 16460 2-s2.0-18144411313 10.1074/jbc.M501485200 (Pubitemid 40616776)
132. Arunachalam G., Yao H., Sundar I. K., Caito S., Rahman I., SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochemical and Biophysical Research Communications 2010 393 1 66 72 2-s2.0-77249158771 10.1016/j.bbrc.2010.01.080
133. Haigis M. C., Sinclair D. A., Mammalian sirtuins: biological insights and disease relevance. Annual Review of Pathology 2010 5 253 295 2-s2.0-77949887506 10.1146/annurev.pathol.4.110807.092250
134. Baur J. A., Chen D., Chini E. N., Chua K., Cohen H. Y., De Cabo R., Deng C., Dimmeler S., Gius D., Guarente L. P., leng@mit.edu Helfand S. L., Imai S. -I., Itoh H., Kadowaki T., Koya D., Leeuwenburgh C., Mcburney M., Nabeshima Y. O.-I., Neri C., Oberdoerffer P., Pestell R. G., Rogina B., Sadoshima J., Sartorelli V., Serrano M., Sinclair D. A., Steegborn C., Tatar M., marctatar@brown.edu Tissenbaum H. A., Tong Q., Tsubota K., Vaquero A., Verdin E., Dietary restriction: standing up for sirtuins. Science 2010 329 5995 1012 1013 10.1126/science.329.5995.1012
135. Dela F., Kjaer M., Resistance training, insulin sensitivity and muscle function in the elderly. Essays in Biochemistry 2006 42 75 88 2-s2.0-35348818333 10.1042/bse0420075
136. Winett R. A., Carpinelli R. N., Potential health-related benefits of resistance training. Preventive Medicine 2001 33 5 503 513 2-s2.0-0034766713 10.1006/pmed.2001.0909 (Pubitemid 33035794)
137. Lira V. A., Benton C. R., Yan Z., Bonen A., abonen@uoguelph.ca PGC-1 α regulation by exercise training and its influences on muscle function and insulin sensitivity. American Journal of Physiology 2010 299 2 E145 E161 10.1152/ajpendo.00755.2009
138. Yan Z., Exercise, PGC-1 α and metabolic adaptation in skeletal muscle. Applied Physiology, Nutrition and Metabolism 2009 34 3 424 427 2-s2.0-67651211228 10.1139/H09-030
139. Petersen A. M. W., Pedersen B. K., The anti-inflammatory effect of exercise. Journal of Applied Physiology 2005 98 4 1154 1162 2-s2.0-15444374348 10.1152/japplphysiol.00164.2004 (Pubitemid 40396484)
140. Jorgensen S. B., Rose A. J., How is AMPK activity regulated in skeletal muscles during exercise? Frontiers in Bioscience 2008 13 5589 5604 2-s2.0-52049119010
141. Lee J. O., Lee S. K., Jung J. H., Kim J. H., You G. Y., Kim S. J., Park S. H., Uhm K.-O., Kim H. S., anatomykim@korea.ac.kr Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells. Journal of Cellular Physiology 2011 226 4 974 981 10.1002/jcp.22410
142. Lee W. J., Kim M., Park H. S., Kim H. S., Jeon M. J., Oh KI. S., Koh E. H., Won J. C., Kim M. S., Oh G. T., Yoon M., Lee KI. U., Park J. Y., AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPAR α and PGC-1. Biochemical and Biophysical Research Communications 2006 340 1 291 295 2-s2.0-29244436681 10.1016/j.bbrc.2005.12.011 (Pubitemid 41827679)
143. Michael L. F., Wu Z., Cheatham R. B., Puigserver P., Adelmant G., Lehman J. J., Kelly D. P., Spiegelman B. M., Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 3820 3825 2-s2.0-0035957375 10.1073/pnas.061035098 (Pubitemid 32249855)
144. Quintanilla R. A., Jin Y. N., Fuenzalida K., Bronfman M., Johnson G. V. W., gailjohnsonvoll@urmc.rochester.edu Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor- γ (PPAR γ) in the pathogenesis of huntington disease. The Journal of Biological Chemistry 2008 283 37 25628 25637 10.1074/jbc.M804291200